BridgeBio Oncology Therapeutics
About:
BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.
Website: https://bridgebiooncology.com
Top Investors: Wellington Management, Enavate Sciences, Google Ventures, Cormorant Asset Management, Omega Funds
Description:
BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.
Total Funding Amount:
$200M
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2014-01-01
Founders:
Eli M. Wallace
Number of Employees:
501-1000
Last Funding Date:
2024-05-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai